Summit Therapeutics

Summit is a UK company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. Our strategy focuses on two therapy areas: Duchenne Muscular Dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria C. difficile.
Company Growth (employees)
Milton, GB
Size (employees)
37 (est)+61%
Summit Therapeutics was founded in 2003 and is headquartered in Milton, GB

Summit Therapeutics Office Locations

Summit Therapeutics has offices in Milton and Cambridge
Milton, GB (HQ)
Park House Park Dr 85b
Cambridge, US
1 Broadway

Summit Therapeutics Data and Metrics

Summit Therapeutics Financial Metrics

Summit Therapeutics's revenue was reported to be £1.5 m in FY, 2016 which is a 32% decrease from the previous period.

Revenue (FY, 2016)

1.5 m

Revenue growth (FY, 2015 - FY, 2016), %


Net income (FY, 2016)

(17.1 m)

Market capitalization (22-Sep-2017)

120.8 m

Closing share price (22-Sep-2017)


Cash (31-Jan-2016)

16.3 m
Summit Therapeutics's current market capitalization is £120.8 m.
GBPFY, 2014FY, 2015FY, 2016


1.8 m2.1 m1.5 m

Revenue growth, %


Pre tax profit

(6.7 m)(12.7 m)(20.1 m)

Net Income

(6.1 m)(11.4 m)(17.1 m)
GBPFY, 2014FY, 2015FY, 2016


2 m11.3 m16.3 m

Current Assets

3.1 m15.2 m20.9 m


43 k55 k83 k


4.2 m4.1 m4.1 m
GBPFY, 2014FY, 2015FY, 2016

Cash From Operating Activities

(5.9 m)(11.3 m)(17.2 m)

Cash From Financing Activities

4.5 m20.5 m22.1 m

Income Taxes Paid

607 k1.3 m3.1 m
GBPY, 2016


63.1 k

Financial Leverage

1.2 x
Show all financial metrics

Summit Therapeutics Market Value History

Traffic Overview of Summit Therapeutics

Summit Therapeutics Online and Social Media Presence

Summit Therapeutics News and Updates

BRIEF-First patient enrolled in Summit's PhaseOut DMD

* Anticipates reporting data periodically during trial with 24-week muscle biopsy data from first group of patients enrolled expected in jan 2017

Summit Therapeutics Company Life and Culture

You may also be interested in